Table 2.
Author | Age/Sex | Associated Tumor | Primary syndrome at Diagnosis | Symptoms | Treatment | Treatment response |
---|---|---|---|---|---|---|
Current Study | 67/F | SCLC | Brainstem, PCD | Opsoclonus-Myoclonus Syndrome, Dysautonomia | Methylprednisolone, Plasmapheresis, IVIG, Lobectomy, Cyclophosphamide | none |
Salazar et al. 2018 [9] | 70/M | None, sCJD | Brainstem, PCD | Dementia, Ataxia, Myoclonus, Dysautonomia | Methylprednisolone | none |
Eye et al. 2018 [10] | 94/F |
DLBCL, SMM |
PCD | Downbeat Nystagmus, alternating Skew Deviation, Gait Ataxia |
Chemotherapy, Rituximab |
Improvement but persisting symptoms |
Aydin et al. 2018 [11] | 40/F | Ductal breast cancer | SSN | Pain, Asymmetric Numbness | n/a | Improvement but persisting symptoms |
Kerasnoudis et al. 2011 [12] | 60/F | Ovarian adenocarcinoma | PCD | Progressive Gait Ataxia, Dysarthria |
Methylprednisolone, Ovariectomy, Chemotherapy |
Complete clinical remission |
Sabater et al. 2008 [8] | n/a | SCLC | PCD | n/a | n/a | n/a |
Bataller et al. 2004 [6] |
67a/ 8: M, 1: F |
8: SCLC 1: no tumor |
7: PCD 1: PCD + LE 1: LEMS |
Cerebellar Ataxia Cerebellar Ataxia, Cognitive Dysfunction Myasthenia |
n/a | n/a |
amedian age